background
impact
differ
class
microbi
pathogen
mortal
sever
communityacquir
pneumonia
well
elucid
previou
studi
shown
signific
variat
incid
viral
bacteri
mix
infect
conflict
risk
associ
mortal
aim
determin
risk
associ
microbi
aetiolog
hospit
mortal
sever
cap
utilis
diagnost
strategi
incorpor
molecular
test
primari
hypothesi
respiratori
virus
import
caus
pathogen
sever
cap
associ
increas
mortal
present
bacteri
pathogen
mix
viralbacteri
coinfect
method
retrospect
cohort
studi
januari
juli
conduct
tertiari
hospit
medic
intens
care
unit
eastern
singapor
tropic
climat
patient
diagnos
sever
communityacquir
pneumonia
includ
result
total
patient
studi
microbi
pathogen
identifi
patient
mix
viralbacteri
coinfect
occur
patient
isol
viral
infect
present
patient
isol
bacteri
infect
detect
patient
hospit
mortal
occur
patient
common
bacteria
isol
streptococcu
pneumonia
common
viru
isol
influenza
univari
multivari
logist
regress
show
serum
procalcitonin
apach
ii
sever
score
mix
viralbacteri
infect
associ
increas
risk
hospit
mortal
mix
viralbacteri
coinfect
associ
adjust
odd
ratio
ci
p
hospit
mortal
conclus
respiratori
virus
common
organ
isol
sever
communityacquir
pneumonia
mix
viralbacteri
infect
may
associ
increas
risk
mortal
microbi
aetiolog
sever
communityacquir
pneumonia
cap
remain
vari
throughout
world
influenc
due
season
climat
chang
outreach
vaccin
programm
pathogen
endem
two
decad
ago
thought
virus
play
minor
role
pathogenesi
sever
cap
notwithstand
influenza
epidem
recent
literatur
contradict
suggest
virus
frequent
found
sever
cap
advanc
molecular
techniqu
improv
sensit
accuraci
turnaround
time
microbi
diagnost
test
avail
highli
multiplex
commerci
test
kit
common
viral
bacteri
pathogen
enabl
test
perform
larg
number
patient
simultan
across
varieti
clinic
set
multipl
respiratori
virus
may
present
concurr
coexist
bacteri
pathogen
caus
diseas
report
incid
virus
sever
cap
result
respiratori
failur
rang
variat
detect
rate
virus
reflect
potenti
limit
avail
test
assay
heterogen
physician
practic
viral
microbi
diagnost
test
perform
postul
prohibit
factor
routin
perform
viral
diagnost
test
patient
sever
cap
may
includ
lack
clear
clinic
guidelin
perceiv
low
costeffect
pauciti
effect
antivir
therapi
respiratori
virus
influenza
primari
aim
studi
determin
risk
associ
microbi
aetiolog
hospit
mortal
sever
cap
utilis
diagnost
strategi
incorpor
molecular
test
primari
hypothesi
respiratori
virus
import
caus
pathogen
sever
cap
associ
increas
mortal
present
bacteri
pathogen
mix
viralbacteri
coinfect
retrospect
cohort
studi
perform
medic
intens
care
unit
tertiari
teach
hospit
singapor
ethic
approv
obtain
singhealth
centralis
institut
review
board
cirb
waiver
consent
adult
age
admit
medic
intens
care
unit
sever
cap
januari
juli
includ
written
electron
medic
record
review
cap
defin
acut
infect
lung
parenchyma
associ
acut
chest
radiograph
infiltr
follow
fever
higher
hypothermia
less
new
cough
dyspnea
explain
reason
worsen
cough
chang
respiratori
secret
patient
preexist
chronic
cough
symptom
present
time
within
h
hospit
admiss
chest
radiograph
report
hospit
radiologist
obtain
confirm
presenc
radiograph
pulmonari
infiltr
patient
shock
requir
vasopressor
support
mechan
ventil
minor
criteria
pneumonia
sever
defin
infecti
diseas
societi
americaamerican
thorac
societi
consid
sever
cap
minor
criteria
includ
respiratori
rate
breath
per
minut
greater
pao
fio
ratio
equal
less
multilobar
pulmonari
infiltr
confus
disorient
blood
urea
nitrogen
equal
greater
mgdl
leukopenia
white
blood
cell
count
less
cellsmm
hypothermia
indic
core
bodi
temperatur
less
hypotens
requir
aggress
fluid
resuscit
patient
prior
hospitalis
within
day
studi
enrol
activ
chemotherapi
neoplast
diseas
receiv
renal
replac
therapi
haemodialysi
prison
exclud
immunocompromis
patient
exclud
like
cap
microbi
pathogen
well
opportunist
infect
time
admiss
intens
care
unit
verifi
electron
record
patient
least
set
aerob
anaerob
blood
cultur
perform
within
h
admiss
routin
collect
endotrach
aspir
gram
stain
semiquantit
bacteri
cultur
occur
within
h
intub
viral
atyp
pathogen
polymeras
chain
reaction
pcr
amplif
test
collect
endotrach
aspir
sputum
sampl
sent
bacteri
aerob
cultur
nasopharyng
swab
perform
atyp
pathogen
viral
pcr
amplif
test
subject
requir
intub
urinari
sampl
test
presenc
urinari
streptococcu
pneumonia
antigen
legionella
pneumophilia
serogroup
antigen
patient
without
anuria
indic
acidfast
stain
mycobacteri
cultur
respiratori
sampl
perform
nucleic
acid
extract
swab
respiratori
sampl
use
viru
mini
kit
cat
qiagen
germani
perform
semiautom
system
qiagen
germani
store
detail
molecular
test
besid
routin
standard
clinic
test
addit
multiplex
realtim
pcr
test
perform
extract
sampl
anyplex
written
electron
medic
record
review
clinic
data
laboratori
indic
sever
valu
record
analysi
blood
test
repeat
within
h
intens
care
admiss
serum
creactiv
protein
measur
particl
enhanc
immunoturbidimetri
serum
procalcitonin
measur
use
sandwich
immunoassay
elecsi
brahm
pct
variabl
acut
physiolog
chronic
health
evalu
ii
apach
ii
sever
score
presenc
shock
mechan
ventil
intens
care
unit
length
stay
mortal
captur
prospect
part
administr
clinic
care
audit
empir
antibiot
deem
adequ
adher
hospit
antimicrobi
guidelin
combin
therapi
betalactam
macrolid
recommend
melioidosi
suspect
carbapenem
prefer
class
betalactam
categor
variabl
express
number
percentag
normal
distribut
quantit
variabl
express
mean
standard
deviat
categor
variabl
compar
chisquar
test
fisher
exact
test
quantit
variabl
compar
ttest
mannu
whitney
test
primari
outcom
measur
allcaus
hospit
mortal
demograph
diseas
variabl
includ
univari
multivari
logist
regress
model
pneumonia
symptom
exclud
regress
analysi
known
associ
mortal
sever
cap
variabl
number
coexist
pathogen
exclud
regress
analysi
due
signific
overlap
mix
viralbacteri
coinfect
includ
multivari
model
follow
sever
indic
shock
alter
mentat
ventil
support
includ
variabl
incorpor
apach
ii
sever
score
mycobacterium
tuberculosi
classifi
bacterium
logist
regress
demograph
diseas
variabl
compar
patient
without
viru
infect
identif
potenti
risk
factor
associ
acquisit
respiratori
viral
infect
pvalu
consid
signific
miss
data
exclud
univari
multivari
analysi
stata
special
edit
version
statacorp
llc
texa
usa
use
statist
analysi
one
hundr
seventeen
patient
admit
medic
intens
care
unit
sever
cap
within
studi
period
baselin
characterist
patient
suffer
inhospit
mortal
n
compar
patient
surviv
tabl
note
patient
surviv
older
compar
survivor
year
vs
year
p
baselin
demograph
comorbid
variabl
significantli
differ
blood
cultur
respiratori
specimen
cultur
respiratori
specimen
pcr
test
virus
atyp
bacteria
perform
patient
result
microbiolog
test
present
tabl
caus
microbi
aetiolog
identifi
patient
specif
organ
present
tabl
major
pathogen
identifi
respiratori
virus
bacteria
virus
found
patient
n
common
viru
influenza
n
patient
influenza
receiv
empir
oseltamivir
basi
clinic
suspicion
bacteri
infect
found
patient
n
patient
n
mix
viru
bacteri
coinfect
patient
viral
pathogen
patient
bacteri
pathogen
found
microbi
aetiolog
sever
cap
use
hospit
mortal
primari
outcom
univari
logist
regress
perform
tabl
patient
surviv
higher
apach
ii
score
higher
serum
procalcitonin
level
microbiolog
aetiolog
significantli
associ
increas
hospit
mortal
detect
mix
viralbacteri
coinfect
multivari
analysi
apach
ii
sever
score
serum
procalcitonin
mix
viralbacteri
coinfect
remain
significantli
associ
increas
adjust
odd
ratio
hospit
mortal
apach
ii
sever
score
known
predict
mortal
sever
cap
studi
found
presenc
mix
viralbacteri
coinfect
associ
increas
hospit
mortal
adjust
odd
ratio
confid
interv
p
patient
respiratori
virus
detect
isol
viral
pathogen
mix
viralbacteri
coinfect
compar
patient
respiratori
viru
infect
tabl
mean
serum
creactiv
protein
found
greater
mgl
vs
mgl
patient
without
respiratori
virus
compar
patient
detect
respiratori
virus
tabl
respiratori
viru
infect
caus
sever
acut
respiratori
distress
syndrom
wellestablish
literatur
data
miss
patient
howev
signific
contributori
pathogen
outcom
sever
cap
uncertain
studi
show
respiratori
virus
commonli
found
bacteria
vs
aetiolog
pathogen
mix
viralbacteri
coinfect
occur
patient
associ
adjust
odd
ratio
hospit
mortal
impact
respiratori
virus
prognosi
sever
cap
remain
unclear
recent
studi
demonstr
contradictori
result
fisher
et
al
prospect
microbiolog
survey
nosocomi
pneumonia
cap
complic
respiratori
failur
show
patient
viral
infect
associ
hospit
mortal
howev
siow
et
al
found
viral
infect
independ
associ
lower
hospit
mortal
compar
microbi
aetiolog
adjust
odd
ratio
ci
p
light
find
accur
characteris
impact
microbi
aetiolog
outcom
sever
cap
requir
influenc
futur
develop
rapid
molecular
diagnost
assay
novel
antimicrobi
therapi
would
target
virus
bacteria
piralla
et
al
review
microbiolog
data
sever
cap
northern
itali
winterspr
season
year
found
patient
one
respiratori
virus
identifi
common
virus
isol
influenza
rhinoviru
similar
find
studi
perform
tropic
countri
local
microbiolog
surveil
shown
influenza
epidem
occur
twice
annual
would
mean
influenza
season
occur
cours
studi
molecular
mechan
viral
pathogenesi
sever
pneumonia
well
studi
influenza
streptococcu
pneumonia
coinfect
viral
infect
alter
host
immun
respons
increas
suscept
bacteri
infect
viralinduc
interferon
clinic
suspicion
alon
n
patient
influenza
studi
receiv
empir
oseltamivir
author
postul
incorpor
earli
influenza
diagnost
test
may
decreas
time
effect
antivir
therapi
second
common
viru
detect
studi
rhinoviru
n
associ
rhinoviru
sever
pneumonia
previous
shown
surveil
program
middl
east
respiratori
syndrom
coronaviru
saudi
arabia
genotyp
c
associ
sever
pneumonia
inhospit
mortal
rate
patient
immunocompromis
chronic
lung
diseas
risk
sever
reason
viral
infect
may
less
promin
caus
sever
cap
prior
decad
firstli
et
al
perform
prospect
observ
studi
physician
practic
use
respiratori
viru
diagnost
demonstr
despit
clinic
guidelin
recommend
test
respiratori
virus
influenza
season
less
half
patient
admit
intens
care
unit
pneumonia
test
viral
pathogen
may
led
underrecognit
true
signific
viral
pathogen
mix
viralbacteri
infect
outcom
sever
pneumonia
factor
may
contribut
underdiagnosi
viral
pneumonia
includ
unavail
cost
molecular
diagnost
assay
lack
effect
antivir
therapi
howev
author
argu
age
globalis
highli
virul
respiratori
virus
potenti
spread
rapidli
constant
surveil
requir
detect
outbreak
implement
isol
precaut
time
manner
understand
signific
respiratori
virus
pathogenesi
sever
cap
would
guid
administr
resourc
alloc
implement
vaccin
program
atrisk
popul
high
rate
complianc
perform
respiratori
aerob
cultur
blood
aerob
anaerob
cultur
studi
accord
sepsi
guidelin
common
bacteri
pathogen
found
streptococcu
pneumonia
consist
known
epidemiolog
cap
global
gadsbi
et
al
prior
studi
abl
demonstr
bacteri
yield
respiratori
specimen
patient
cap
test
bacteri
multiplex
pcr
incorpor
use
bacteri
multiplex
pcr
futur
studi
may
increas
rate
bacteria
detect
shed
light
potenti
molecular
synerg
specif
virus
bacteria
pathogenesi
sever
cap
pulmonari
tuberculosi
endem
region
studi
perform
studi
patient
tuberculosi
one
concomit
adenoviru
infect
anoth
streptococcu
pneumonia
initi
present
pulmonari
tuberculosi
clinic
featur
consist
sever
cap
describ
tseng
et
al
patient
pulmonari
tuberculosi
present
respiratori
failur
septic
shock
author
postul
pulmonari
tuberculosi
may
play
role
increas
host
suscept
sever
infect
cap
organ
author
recognis
sever
limit
studi
firstli
firstdos
antibiot
would
administ
soon
sepsi
identifi
unabl
accur
defin
time
administr
antibiot
collect
specimen
microbiolog
assess
may
affect
yield
secondli
inher
retrospect
natur
studi
increas
risk
bia
data
collect
howev
part
preestablish
intens
care
unit
clinic
audit
avail
nation
health
record
clinic
data
particip
demograph
comorbid
ill
sever
indic
apach
ii
establish
time
intens
care
admiss
store
prospect
thirdli
given
high
popul
densiti
countri
world
studi
perform
microbi
epidemiolog
sever
cap
may
extrapol
urban
set
studi
singlecentr
survey
conduct
acut
gener
hospit
serv
popul
million
land
area
km
henc
epidemiolog
may
lack
generalis
extrapol
tropic
countri
fourth
limit
includ
patient
immunocompromis
typic
cap
organ
surviv
may
potenti
opportunist
infect
detect
howev
contribut
mortal
outcom
felt
microbiolog
data
contribut
patient
use
understand
preval
variou
data
present
number
mean
standard
deviat
apach
acut
physiolog
chronic
health
evalu
data
miss
patient
b
data
miss
patient
class
cap
organ
lastli
anoth
potenti
limit
vaccin
record
could
retriev
unabl
ascertain
influenc
microbi
aetiolog
sever
pneumonia
studi
popul
main
strength
studi
characteris
epidemiolog
microbi
pathogen
sever
cap
abl
show
tropic
environ
viral
bacteri
pathogen
associ
sever
cap
similar
region
season
climat
despit
lowerthanexpect
mortal
rate
sever
cap
studi
compar
intern
data
abl
demonstr
mix
viralbacteri
coinfect
independ
associ
hospit
mortal
respiratori
virus
import
caus
pathogen
sever
cap
associ
increas
risk
mortal
present
bacteri
pathogen
mix
viralbacteri
coinfect
abbrevi
apach
ii
acut
physiolog
chronic
health
evalu
ii
cap
communityacquir
pneumonia
pcr
polymeras
chain
reaction
